Finding inflammatory bowel disease genes will not lead to a cure

Canadian Journal of Gastroenterology

Volumn 20, Issue 10, 2006, Pages 643-644

  Marshall, John K ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

CROHN DISEASE; ENTERITIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; GENETIC PREDISPOSITION; HEREDITY; HUMAN; HYGIENE; IMMUNE RESPONSE; LIFESTYLE; MARKER GENE; MICROBIAL COLONIZATION; MIGRATION; MONOZYGOTIC TWINS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOCIAL STATUS; ULCERATIVE COLITIS; URBANIZATION;

EID: 33751246167     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2006/814145     Document Type: Review

References (28)

1. Tysk C, Lindberg E, Jamerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988;29:990-6.
2. Omholm M, Binder V, Sorensen TI, Rasmussen LP, Kyvik KO. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol 2000;35:1075-81.
3. Hugot JP, Cezard JP, Colombel JF, et al; GETAID. Clustering of Crohn's disease within affected sibships. Eur J Hum Genet 2003;11:179-84.
4. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
5. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
6. Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005;307:731-4.
7. Maeda S, Hsu LC, Liu H, et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005;307:734-8. (Erratum in 2005;308:633).
8. Newman B, Siminovitch KA. Recent advances in the genetics of inflammatory bowel disease. Curr Opin Gastroenterol 2005;21:401-7.
9. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-17.
10. Montgomery SM, Morris DL, Pounder RE, Wakefield AJ. Asian ethnic origin and the risk of inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999;11:543-6.
11. Wright JP, Froggatt J, O'Keefe EA, et al. The epidemiology of inflammatory bowel disease in Cape Town 1980-1984. S Afr Med J 1986;70:10-5.
12. Weinstock JV, Summers R, Elliott DE. Helminths and harmony. Gut 2004;53:7-9.
13. Korzenik JR. Past and current theories of etiology of IBD: Toothpaste, worms, and refigerators. J Clin Gastroenterol 2005;39:S59-65.
14. Van Ranst M, Joossens M, Joossens S, et al. Crohn's disease and month of birth. Inflamm Bowel Dis 2005;11:597-9.
15. Chowers Y, Odes S, Bujanover Y, Eliakim R, Bar Meir S, Avidan B. The month of birth is linked to the risk of Crohn's disease in the Israeli population. Am J Gastroenterol 2004;99:1974-6.
16. Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994;343:766-7.
17. Duggan AE, Usmani I, Neal KR, Logan RF. Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: A case-control study. Gut 1998;43:494-8.
18. Whorwell PJ, Holdstock G, Whorwell GM, Wright R. Bottle feeding, early gastroenteritis, and inflammatory bowel disease. Br Med J 1979;1:382.
19. Ekbom A, Adami HO, Helmick CG, Jonzon A, Zack MM. Perinatal risk factors for inflammatory bowel disease: A case-control study. Am J Epidemiol 1990;132:1111-9.
20. Koletzko S, Sherman P, Corey M, Griffiths A, Smith C. Role of infant feeding practices in development of Crohn's disease in childhood. BMJ 1989;298:1617-8.
21. Montgomery SM, Pounder RE, Wakefield AJ. Infant mortality and the incidence of inflammatory bowel disease. Lancet 1997;349:472-3.
22. Hugot JP, Alberti C, Berrebi D, Bingen E, Cezard JP. Crohn's disease: The cold-chain hypothesis. Lancet 2003;362:2012-5.
23. Vandenbroucke K, Hans W, Van Huysse J, et al. Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology 2004;127:502-13.
24. McCarthy J, O'Mahony L, O'Callaghan L, et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003;52:975-80.
25. Steidler L, Hans W, Schotte L, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000;289:1352-5.
26. Madsen KL, Doyle JS, Tavemini MM, Jewell LD, Rennie RP, Fedorak RN. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology 2000;118:1094-105.
27. Kleessen B, Kroesen AJ, Buhr HJ, Blaut M. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol 2002;37:1034-41.
28. Steinhart AH, Feagan BG, Wong CJ, et al. Combined budesonide and antibiotic therapy for active Crohn's disease: A randomized controlled trial. Gastroenterology 2002;123:33-40.